Evidence map›Paper›PMID 36882402›Full record

ArticleScientific data2023

An Online Mammography Database with Biopsy Confirmed Types.

Hongmin Cai, Jinhua Wang, Tingting Dan, Jiao Li, Zhihao Fan, Weiting Yi, Chunyan Cui, Xinhua Jiang, Li Li

Open access · goldAbstract readDataset
In one paragraph

Article in Scientific data, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Hongmin Cai *School of Computer Science and Engineering, South China University of Technology, Guangzhou, 510006, China. hmcai@scut.edu.cn.ORCID 0000-0002-2747-7234
Jinhua Wang *Medical Imaging Center, Shenzhen Hospital, Southern Medical University, Shenzhen, 510515, China.
Tingting Dan *School of Computer Science and Engineering, South China University of Technology, Guangzhou, 510006, China.
Jiao LiDepartment of Medical Imaging, Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Zhihao FanSchool of Computer Science and Engineering, South China University of Technology, Guangzhou, 510006, China.
Weiting YiSchool of Computer Science and Engineering, South China University of Technology, Guangzhou, 510006, China.
Chunyan CuiDepartment of Medical Imaging, Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Xinhua JiangDepartment of Medical Imaging, Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Li LiDepartment of Medical Imaging, Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. li2@mail.sysu.edu.cn.
South China University of Technology · CNSun Yat-sen University · CNThird Affiliated Hospital of Southern Medical University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 62172112National Natural Science Foundation of China (National Science Foundation of China) U21A20520
6 · The paper itself

Abstract

Breast carcinoma is the second largest cancer in the world among women. Early detection of breast cancer has been shown to increase the survival rate, thereby significantly increasing patients' lifespan. Mammography, a noninvasive imaging tool with low cost, is widely used to diagnose breast disease at an early stage due to its high sensitivity. Although some public mammography datasets are useful, there is still a lack of open access datasets that expand beyond the white population as well as missing biopsy confirmation or with unknown molecular subtypes. To fill this gap, we build a database containing two online breast mammographies. The dataset named by Chinese Mammography Database (CMMD) contains 3712 mammographies involved 1775 patients, which is divided into two branches. The first dataset CMMD1 contains 1026 cases (2214 mammographies) with biopsy confirmed type of benign or malignant tumors. The second dataset CMMD2 includes 1498 mammographies for 749 patients with known molecular subtypes. Our database is constructed to enrich the diversity of mammography data and promote the development of relevant fields.

Indexed as

Breast DiseasesBreast NeoplasmsMammographyBiopsyFemaleHumans

Identifiers

PMID36882402
PMCPMC9992520
OpenAlexW4323363608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.